Over the years, Kennedy Krieger’s scientists and researchers have made crucial medical discoveries that have led to innovative treatments and improved patient care for individuals with disorders of the brain, spinal cord and musculoskeletal system.

To learn more about research studies currently recruiting participants, click the links below:

Attention-Deficit/Hyperactivity Disorder (ADHD)

Children between the ages of 6 to 12 years currently receiving treatment for ADHD who demonstrate traits of impulsive aggression

Children, ages 8-12, with and without ADHD

Autism Spectrum and Pervasive Developmental Disorders

Children, ages 4-18 years of age

Children, 8-12 months of age, with no visual or hearing impairments

Children, 12-36 months of age

Help Speed Up Autism Research - Join SPARK Today

Children ages 8-12 with and without autism spectrum disorders

Children and adults ages 5-21 with autism spectrum disorders

Children ages 4.0-12.0 years with autism spectrum disorders

Identical twin sets ages 3-30, boys or girls, either one or both with Autism

Behavioral Disorders/Self Injurious Behavior

Children, ages 2-5 years, who have behavior problems

Bipolar Disoder

Children with Bipolar Disorder

Brain Injury (BI)

Typically developing children ages 14-18 years

Children aged 8-18 years who have had a traumatic brain injury

Children aged 10-17 years with traumatic brain injury

Typically Developing Children and Adults, Ages 3-20

Cancer

School-aged or older child who has been treated for cancer and has returned to a formal school setting

Concussion

Right-Handed Teenagers, 13-17 Years Old, with a Sports-Related Concussion

Right-Handed Teenagers, 13-17 Years Old, Who Have Never Had a Concussion

Down Syndrome

Individuals ages 7-17 with Down syndrome (Brochure)

Individuals ages 7-17 with Down syndrome (Flyer)

Children and adolescents ages 10-17 with Down syndrome

Dyslexia

Children, ages 8-12 years, with Dyslexia

Learning Disorders (LD)

Children ages 6-11 years and their parents to participate in a behavior and genetics research study

Children and young adults, age 8-15

Major Depressive Disorder

Children between the ages of 7 and 17 years diagnosed with major depressive disorder (MDD) being treated for MDD as an outpatient

Muscular Dystrophy

Males with DMD >=4 and <8 years of age

Adults with FSHD and their first degree unaffected relative

Adults with FSHD and their first degree unaffected relative 18 years of age or older

Ambulatory males with DMD 5 -18 years of age

Prematurity

Children aged 6-8 years with and without a history of iron deficiency

Psychiatric Disorders

CLINICAL TRIAL: Investigational Drug for Schizophrenia in Adolescents, Ages 12 to 16

Investigational Drug for Bipolar I Disorder in Children and Adolescents, Ages 10 to 17

CLINICAL TRIAL: Investigational Drug for Schizophrenia in Adolescents, Ages 13 to 17

Rett Syndrome

CLINICAL TRIAL: Children ages 1-9.99 years of age with MECP2 mutation

Sleep Disorders

CLINICAL TRIAL: Children and adolescents with neurodevelopmental disabilities and sleep problems, ages 2-17.5

Slow Moving

Children between the ages of 6 to 11 years who work more slowly than their siblings or peers

Spinal Cord Injury and Paralysis

Adults, age 18-80 with ASIA A-D cervical (C4-C7) injury

Adults, age 18-65 with diagnosis of transverse myelitis, or multiplesclerosis, or neuromyelitis optica

Adults, age 18-65 with complete spinal cord injury at any level (ASIA A)

Adults, age 18-65 with spinal cord injury

Adults, age 18-55 with cervical spinal cord injury

Adults, age 18-55 with spinal cord injury who want to learn how to sail

Sturge-Weber Syndrome (SWS)

Sirolimus Research Study for Cognitive Impairments in Sturge-Weber syndrome

Tuberous Sclerosis Complex (TSC)

CLINICAL TRIALS:Children ages 4-15 years with Tuberous Sclerosis Complex, autism, and seizures

CLINICAL TRIAL: Tuberous Sclerosis (TSC) patients of all ages with visible facial angiofibromas